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Background: Percutaneous needle autopsy can overcome a number of barriers that limit the use of complete
autopsies. We performed blind-and ultrasound guided needle autopsies in HIV-infected adults in Uganda. In this
study we describe in detail the methods we used, the ability of both procedures to obtain sufficient tissue for
further examination and the learning curve of the operators over time.
Methods: If written informed consent was granted from the next of kin, we first performed a blind needle autopsy,
puncturing brain, heart, lungs, liver, spleen and kidneys using predefined surface marking points. We then
performed an ultrasound guided needle autopsy puncturing heart, liver, spleen and kidneys. The number of
attempts, expected success and duration of the procedure were noted. A pathologist read the slides and indicated
if the target tissue was present and of sufficient quality for pathological review. We report the predicted and true
success rates, compare the yield of blind to ultrasound guided needle biopsies and evaluate the failure rate over
time.
Results: Two operators performed 96 blind needle autopsies and 95 ultrasound guided needle autopsies. For blind
needle biopsies true success rates varied from 56-99% and predicted success rates from 89-99%. For ultrasound
guided needle biopsies true success rates varied from 72-100% and predicted success rates from 84-98%.
Ultrasound guidance led to a significantly higher success rate in heart and left kidney. A learning curve was observed
over time with decreasing failure rates with increasing experience and a shorter duration of the needle autopsy.
Conclusion: Needle autopsy can successfully obtain tissue for further pathological review in the vast majority of
cases, with a decrease in failure rate with increasing experience of the operator. The benefit of ultrasound guidance
will depend on the population, the disease and organ of interest and the local circumstances. Our results justify
further evaluation of needle autopsies as a method to establish a cause of death.
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Needle autopsy was first described in 1955 when in 24
corpses tissue was obtained by percutaneous biopsies. Its
use was motivated by low acceptance rates and limited ac-
cessibility of complete autopsy outside the hospital [1].
Since then, needle autopsy has been used in various
settings and for various reasons including increased ac-
ceptability, simplicity and decreased risk of disease trans-
mission when compared to complete autopsies [2,3].
However, an important disadvantage of needle autopsy
is the lack of direct visual judgment. This may lead to
sampling error of both the target organ and the target
lesion. Reported success rates to obtain tissue vary
widely depending on the organ involved. The largest
postmortem needle biopsy study retrospectively evalu-
ated 394 biopsies that were performed between 1948
and 1968 by 32 different pathology residents in the
United States. The success rates ranged from 34% for
the kidneys to 92% for the liver [2]. Smaller studies in
various adult populations have shown successful biopsy
rates of 98-100% for the liver, 76-94% for the lungs, 50-
100% for the heart and 10-80% for the kidneys [3-6].
The addition of ultrasound guidance could compen-
sate for the loss of visual judgment. For clinical biopsies
in living patients ultrasound guidance is well established
and used to increase tissue yield and to prevent compli-
cations [7-9]. For needle autopsies, the use of ultrasound
guidance was reported in one study [10]. However, since
postmortem there is no apparent limit to the number of
biopsies and complications no longer need to be pre-
vented, its benefit may be less obvious.
We conducted a study in Uganda in which we subse-
quently performed blind needle autopsy, ultrasound
guided needle autopsy and complete autopsy in deceased
HIV-infected hospitalized adults. Our results on the con-
cordance in cause of death between needle and complete
autopsy have been published elsewhere [11]. Herein, we
report in detail the methods we used, the success rates for
the individual organs and the observed learning curve
over time. Moreover, we compare the success rates per
organ of blind and ultrasound guided needle autopsies.
Methods
Setting and population
The study was conducted in Mulago hospital, a tertiary
teaching hospital in Kampala, Uganda from February until
June 2013. Written informed consent for study participa-
tion was obtained from the next of kin of HIV-infected
adults (>18 years old) that died during hospitalization. Post-
partum deaths and deaths after trauma were excluded.
General information
The needle autopsy took place within 4 hours after
consent was granted. Two medical doctors (JAC, RLL),without previous experience in needle biopsies or ultra-
sound use performed all needle autopsies in the hospital
mortuary. Prior to study initiation, an experienced
radiologist instructed the two medical doctors on the
performance of ultrasound guided needle biopsies. One
automated biopsy needle 14G*16cm (Bard® Max-Core®
disposable core biopsy instrument) was used per patient.
For each procedure the start and end-time were re-
corded. The operator assessed nutritional status on gross
examination of the corpse (emaciated, thin, well nour-
ished or obese). After completing all study procedures
the body was embalmed free of charge and any needle-
entry sites leaking bodily fluids were sutured.
The operator was free to perform as many punctures
as needed, however a minimum of 3 attempts and a rea-
sonable maximum of approximately 10 attempts was set.
The operator noted the number of attempts and the
number of expected successful core biopsies per organ.
The core biopsies (brain, heart, liver, spleen, right and
left kidney, right and left lung) were collected in 3 separ-
ate specimen containers filled with formalin 10%. For
the blind biopsies container 1 collected brain, heart, liver
and spleen, container 2 left kidney and left lung and
container 3 right kidney and right lung. For the ultra-
sound guided biopsies container 1 collected heart, liver
and spleen, container 2 left kidney and container 3 right
kidney.
Autopsy procedures
For the blind needle autopsy, surface marking points
and palpation were used to estimate the location of each
individual target organ. The following surface marking
points for needle entry were used: the brain through the
nose and the cribriform plate, the spleen along the mid-
clavicular line under the rib arch pointing the needle in
dorso-lateral direction or from the 11th intercostal space
mid-axillary in case of a sample error (i.e. no tissue in
the biopsy needle), the liver along the mid-clavicular line
under the rib arch, both lungs at the level of the 3rd
intercostal space below the deltoid tubercle or in case of
a sample error from the 6-7th intercostal space mid-
axillary, the heart 5th intercostal space lateral from the
sternum and both kidneys dorsal below the 12th rib just
lateral from the spine. The operator was allowed to change
the needle position during the procedure if the macro-
scopic appearance of the core biopsy would imply so.
Ultrasound guided needle biopsies were taken from
the heart, liver, spleen and both kidneys using a pocket-
size, portable ultrasound scan (Vscan® V1.2, GE Health-
care, USA). The ultrasound scan was used for real-time
guidance of the needle to the target organ. However, if
the ultrasound scan identified any specific lesion(s) in
the target-organ, an attempt was made to also puncture
this lesion.
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For the needle autopsy, one paraffin-embedded tissue
block was made per specimen container. Therefore, 6
tissue blocks per patient were made with 4/6 tissue
blocks containing core biopsies of more than one organ.
An effort was made by the lab-technicians to embed all
tissue-cores on the same level, so that when cutting the
block all tissue-cores would be present.
From each block, a hematoxylin and eosin (H&E)
stained slide was made. A pathologist read each slide
and noted per slide if the target tissue was present and
of sufficient quality for histological review. If a slide did
not contain all the expected tissues, the block was
reviewed and when needed re-embedded to ensure all
tissue-cores were at one level on the cut-surface. A new
H&E stained slide would be made and reread by the
pathologist in the same manner as before.
Definition of outcomes
A successful biopsy was defined as at least one represen-
tative core biopsy of a specific organ on the slide where
it should be present. This definition was used because
within a patient target tissue could be obtained unin-
tentionally when trying to puncture another organ but
missed when intending to puncture that organ, e.g. heart
tissue could be present on the slide that should contain
left lung but not present on the slide that should contain
heart tissue. In that case, the heart biopsy was classified
as unsuccessful. We report the true success rate, i.e. the
proportion of successful biopsies after histological review
and the predicted success rate, i.e. the proportion of suc-
cessful biopsies predicted by the operators during the
procedure.
Statistical methods
Proportions are reported with 95% confidence intervals
(CI) and medians with inter-quartile ranges (IQR). When
comparing proportions a McNemar test, a Chi square
test or a Fisher’s exact test were performed when appro-
priate. When evaluating the relation between number of
attempts and success rates, logistic regression was used.
A p-value <0.05 was considered statistically significant.
Data were analyzed using STATA version 11.0 (Stata
Corp., College Station, TX, Texas, USA).
Ethics statement
The study received ethical approval from the Joint
Clinical Research Center Research and Ethics Committee
(Uganda), the Mulago Internal Review Board (Uganda)
and the Institute of Tropical Medicine Institutional
Review Board (Belgium). The study received final approval
and registration by the Uganda National Council of
Science and Technology (HS1300).Results
We conducted 96 blind needle autopsies and 95 ultra-
sound guided autopsies; in one patient the ultrasound-
guided biopsy was not performed due to generalized
cutaneous lesions with extreme desquamation. After
processing, 4 kidney-containing ultrasound guided tissue
blocks were missing. Therefore we were able to analyze
768 blind biopsies (8 target organs in 96 patients) and
471 ultrasound-guided biopsies (5 target organs in 95
patients, minus 4).
Fifty-seven percent of patients were female, the me-
dian age was 35 years (IQR 29–40), 31% were classified
emaciated, 38% thin, 27% well nourished and 4% obese.
Nine percent of all tissue blocks were re-embedded after
initial pathological review. No leakage of fluid from
entry-sites was observed and no suturing was performed.
Blind needle autopsy
The true success rates for the different organs varied
from 56-99% (Table 1). The heart had the lowest true
success rate, 56% (95%CI 46-66%), followed by the right
and left lung, respectively 71% (95%CI 62-80%) and 66%
(95%CI 56-75%) and the right and left kidney, respect-
ively 73% (95%CI 64-82%) and 71% (95%CI 62-80%).
When combining the biopsies of the left and right lung
and the left and right kidney for each patient, the true
success rates for the lung increased to 82% (95% CI 75–
90) and for the kidney to 83% (95% CI 76-91%).
The true success rates were significantly lower than
the predicted success rates for all organs, except brain
and liver. The predicted success rates varied from 89-
99% (Table 1).
Because a variable number of attempts were allowed
to obtain a biopsy, we calculated the true success rate
per attempt (Table 1). For this analysis we selected 80
patients for whom the number of attempts was noted
for all 8 target-organs. The true success rates in these 80
patients were not significantly different than the true
success rates of the whole cohort. We found no signifi-
cant correlation between an increasing number of at-
tempts and true success rate in any organ. For the
spleen, an increasing number of attempts lead to a lower
true success rate (p = 0.003).
There were 188 (24%) unsuccessful biopsies in 68
(71%) patients (Table 2). Thirty-five (19%) of these were
predicted by the operator. This could be because of sev-
eral reasons: the operator could have failed to pierce the
cribriform plate in case of a brain biopsy or the macro-
scopic appearance of the core biopsy made the operator
doubt if he/she had punctured the target organ. In 16
(9%) unsuccessful biopsies, the target tissue was present
but of insufficient quality for histological review. Patients
classified as “thin” had more unsuccessful biopsies com-
pared to all others (p = 0.01).
Table 1 Success rates per organ for blind and ultra-sound guided needle biopsies
Blind Ultrasound
Predicted
success rate
(%, 95% CI)
True
success rate
(%, 95% CI)
Median# of
attempts
(IQR)
True success rate/
total# of attempts§
(95% CI)
Predicted
success rate
(%, 95% CI)
True
success rate
(%, 95% CI)
Median# of
attempts
(IQR)
True success rate/
total# of attempts§
(95% CI)
Brain 92 (87–98) 93 (87–98) 3 (3–4) 0.27 (0.26-0.29) - - - -
Lung right 99 (97–100) 71 (62–80)* 5 (4–7) 0.15 (0.12-0.17) - - - -
Lung left 99 (97–100) 66 (56–75)* 5 (4–6) 0.13 (0.11-0.15) - - - -
Both lungs 99 (97–100) 82 (75–90)* 10 (8–12) 0.08 (0.07-0.09) - - - -
Heart 97 (93–100) 56 (46–66)* 4 (3–5) 0.14 (0.11-0.16) 91 (85–97) 72 (62–81)*/** 3 (3–5) 0.20 (0.17-0.23)***
Liver 99 (97–100) 99 (97–100) 3 (3–4) 0.27 (0.26-0.29) 98 (95–100) 100 3 (3–4) 0.29 (0.28-0.30)
Spleen 89 (83–96) 76 (67–85)* 5 (3–7) 0.14 (0.12-0.17) 84 (77–92) 72 (62–81)* 5 (3–6) 0.15 (0.12-0.17)
Kidney right 91 (86–97) 73 (64–82)* 5 (4–6) 0.15 (0.13-0.17) 91 (85–97) 83 (75–91) 4 (3–5) 0.20 (0.18-0.23)***
Kidney left 90 (84–96) 71 (62–80)* 5 (4–6) 0.16 (0.13-0.18) 91 (85–97) 86 (79–93)** 4 (3–6) 0.20 (0.17-0.22)***
Both kidneys 97 (97–100) 83 (76–91)* 10 (8–11) 0.09 (0.08-0.10) 96 (92–100) 91 (86–97) 9 (7–11) 0.11 (0.10-0.11)
CI: Confidence interval; #: Number IQR: Inter quartile range.
§: Selection of 80 patients for which the number of attempts were noted for each organ. True success rates were not significantly different in these 80 patients
when compared to the whole cohort both for blind and ultrasound guided needle biopsies. The minimum number of attempts was 3, therefore the maximum
rate is 0.33.
*: Predicted and true success rate significantly different.
**: True success rate significantly different between blind and ultrasound guided needle biopsy.
***: True success rate/total# of attempts significantly different between blind and ultrasound guided biopsy.
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For the ultrasound-guided biopsies the true success rate
varied from 72-100% (Table 1). The predicted success
rates varied from 84-98% and were significantly higher
than the true success rate for the heart and the spleen.
When considering the same 80-patient subset men-
tioned before, we found a significant correlation with an
increasing number of attempts leading to lower true suc-
cess rates for the heart, the spleen and right kidney (re-
spectively p = 0.002, p = 0.02 and p = 0.01). Ultrasound
imaging detected no specific lesions within the target or-
gans and only once a large abdominal lesion outside a
target organ was seen and successfully punctured.Table 2 Unsuccessful biopsies for each organ
Blind
Total Predicted n (%) QNS n
Brain 7 6 (86) -
Right lung 28 1 (4) 5 (18)
Left lung 33 1 (3) 3 (9)
Heart 42 3 (7) 2 (5)
Liver 1 1 (100) -
Spleen 23 7 (30) -
Right kidney 26 8 (31) 4 (15)
Left kidney 28 8 (29) 2 (7)
Total 188 34 (18) 16 (9)
n: Absolute number; QNS = Quality not sufficient.
*Significantly different when compared to the proportion of predicted unsuccessfulThe use of ultrasound guidance led to a significantly
higher true success rate for the heart (72% versus 56%,
p = 0.03) and the left kidney (86% versus 71%, p = 0.01)
when compared to blind biopsy. The true success rate
for kidney tissue irrespective of the side was not signifi-
cantly different between ultrasound guided and blind
needle autopsy (91% versus 83%, p = 0.09). Moreover, the
true success rate per number of attempts was signifi-
cantly higher with ultrasound guidance for the heart (0.2
versus 0.13, p = 0.0001) and the right kidney (0.2 versus
0.15, p = 0.002). Ultrasound guided needle autopsy had
fewer unsuccessful biopsies (18% versus 24%, p = 0.01)
and more expected unsuccessful biopsies (22% versusUltrasound
(%) Total Predicted n (%) QNS n (%)
- - -
- - -
- - -
27 8 (30) 2 (7)
- - -
27 13 (48) 1 (4)
16 6 (38) -
13 5 (38) -
83 32 (39)* 3 (4)
biopsies in the blind needle autopsy.
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gans that were punctured in both procedures.Experience over time
Operator 1 performed 13 (14%) blind and 12 (13%)
ultrasound guided biopsies and operator 2 performed
the remaining 83 blind and 83 ultrasound-guided biop-
sies. The mean number of unsuccessful biopsies per pa-
tient was similar for both operators when comparing the
blind biopsies from operator 1 (4.3, 95% CI 3.6-5.0) to
the first 13 blind biopsies from operator 2 (3.8, 95% CI
3.1-4.6) and when comparing the ultrasound guided bi-
opsies from operator 1 (2, 95% CI 1,2-2,8) to the first 12
ultrasound-guided biopsies of operator 2 (1.7, 95% CI
1.1-2.2) (Figure 1). For operator 2, over time the cumu-
lative number of unsuccessful biopsies leveled off; when
considering the last 13 blind and last 12 ultrasound
guided biopsies, the mean number of unsuccessful biop-
sies per patient was 0.7 (0.1-1.3) and 0.2 (95% CI 0–0.4)
respectively, implying a learning curve over time for
both procedures.
For operator 1 and 2, the mean duration of the first 13
blind needle biopsies was 25 min (95% CI 19–31) and
20 minutes (95% CI 18–22) respectively. The last 13
blind needle biopsies took performer 2 on average
16 min (95% CI 15–18). For operator 1 and 2 the mean
duration of the first 12 ultrasound-guided biopsies was
24 min (95% CI 18–31) and 23 minutes (95% CI 21–26)
respectively. The last 12 blind needle biopsies took per-
former 2 on average 14 min (95% CI 12–15).Figure 1 Cumulative number of unsuccessful biopsies per operator in
50% of cumulative unsuccessful biopsies for operator 2 in the blind needleDiscussion
We found postmortem needle biopsies using surface
marking-points to be a successful method for obtaining
adequate tissue for further pathological review in the
majority of cases. Operators tended to overestimate the
success of the needle biopsy. The addition of ultrasound
guidance lead to higher true success rates and success
rates per attempt in the heart and the individual kidneys.
A learning curve was observed in the performance of
needle autopsy.
The success rates of blind needle biopsies for the dif-
ferent organs are very comparable to the results of
others that performed needle autopsy in adults; the
heart, the lungs and the kidneys were most difficult to
successfully biopsy [2-4,6]. These organs cannot be easily
palpated, which partly explains why they have the lowest
biopsy success rates. Any benefit of ultrasound guidance
would be expected mainly in those organs and was
indeed found for the heart and the individual kidneys.
Another study that used ultrasound guidance for post-
mortem biopsies of spleen (n = 39), kidneys (n = 39) and
heart (n = 3) reported a yield of respectively 87%, 100%
and 100% [10]. So the tissue yield for certain organs can
be increased by the addition of ultrasound guidance.
However, ultrasound guidance also has disadvantages; it
requires the availability of an ultrasound machine and it
decreases the simplicity of the procedure. Moreover,
ultrasound guidance is unsuitable for some organs (brain
and lungs). Therefore, whether ultrasound guidance
should be recommended depends on the setting and
the organs of interest. In our population of severelyeach subsequent procedure performed. The dashed line indicates
biopsies.
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of ultrasound guidance did not lead to the identification
of more causes of death, however, for other populations
e.g. where renal or cardiac diseases are more prevalent,
this might be different [11].
The entry points we used rely on normative general
anatomy. Alternative entry points have been reported,
although their descriptions are vague: a ‘bonesaw tract’
to biopsy the brain and a ‘lateral position’ to biopsy the
kidneys [4,6]. For organs with a relative low yield alter-
native entry points should be further explored, e.g. below
the xyphoid pointing the needle towards the left axilla
for the heart or the 9th or 10th intercostal space behind
the mid axillary line for the spleen. Moreover, to evalu-
ate and compare needle autopsy it is important to know
what exact methods are being used. Detailed methodo-
logical descriptions, e.g. what needle entry points are
used, how many punctures are performed per organ,
how tissue collection and processing takes place, should
therefore be reported in needle autopsy studies.
We had set a reasonable maximum of 10 biopsy-
attempts per organ and often far fewer attempts were
made. A way to increase the yield could be to increase
the number of attempts. However, we found for some
organs a decrease in success rate with an increasing
number of attempts, implying more punctures were
done on ‘difficult’ organs without increasing the number
of successful punctures. Therefore, merely increasing the
number of attempts will unlikely increase the number of
successful biopsies. Changing the entry point and/or
position during the procedure may increase the success
rate. This information was not collected during our
study. Moreover, we found that predicted success rates
did not correspond well to the true success rates. There-
fore, the judgment of the operator should not be used to
guide the sampling. A possible way forward to increase
tissue yield would be to biopsy organs that are notori-
ously difficult more often and use different entry point
and/or needle positions for each subsequent attempt.
Others showed the degree of experience and motiv-
ation of the person performing the biopsies influenced
the yield [2]. We also observed a clear learning curve
over time. Moreover, the procedure was fast, the visible
marks after the needle autopsy were limited and no
suturing of needle entry points was needed. Although
medically trained people performed the needle autopsies,
they were laymen in the field of needle biopsies. This of-
fers perspectives for needle autopsies to be performed
on a broader scale. Potential possibilities include practice
outside a hospital setting by trained lower level health-
care workers.
This study has several limitations. The reported learn-
ing curve over time is based on the performance of 1
operator. Moreover, the subsequent performance of theblind, ultrasound guided and complete autopsy may have
influenced the learning curve, for example the macro-
scopic assessment of the organs during the complete
autopsy gave the operator feedback on the successful-
ness of the needle autopsy. Also, the increased failure
rate in thin but not in emaciated patients was significant
but difficult to interpret. The assessment of the nutri-
tional status might have been inaccurate and also the
numbers of patients in the categories “well nourished”
and “obese” were small. These results should therefore
be interpreted with caution. Finally, we assumed the ab-
sence of target tissue was the result of a failed biopsy.
However, some small, fragile tissue cores may have also
got lost during tissue processing.
Conclusion
We found that the use of surface marking points led to
adequate tissue cores for further pathological review in
the vast majority of organs assessed. Whether these will
be adequate to diagnose the actual underlying causes of
death depends on the population and the diseases and
organs involved. However, the ability to obtain adequate
tissue biopsies justifies further evaluation of this tech-
nique that overcomes many of the barriers of complete
autopsy practices.
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